...
【24h】

Parathyroid hormone control survey to determine inter-method and inter-lab variations in Japan.

机译:甲状旁腺激素对照调查以确定日本的方法间和实验室间差异。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

For uremic patients, Kidney Disease: Improving Global Outcomes suggest that parathyroid hormone (PTH) levels should be maintained within approximately 2-9 times the upper normal limit for the assay. One of reasons for the lack of definite approximate PTH values is the inability to use the Allegro Intact PTH assay from Nicols. We aimed to evaluate whether other parathyroid hormone assays were suitable for these assessments. We compared the parathyroid hormone concentrations measured with five commercial immunoassays by using three serum pools and seven artificially spiked samples of parathyroid hormone; the Total Intact parathyroid hormone assay was used as the reference assay. Although the results of parathyroid hormone assays showed high correlation, the concentrations differed from Yamasa's assay to another. And the third/second-generation assay ratio was approximately 60%. Further, the Immulite assay overestimated the levels of 1-84 PTH. We showed important inter-method variations in the parathyroid hormone assays used in Japan.
机译:对于尿毒症患者,肾脏疾病:改善总体结果提示甲状旁腺激素(PTH)水平应维持在正常上限上限的2-9倍左右。缺乏确定的近似PTH值的原因之一是无法使用Nicols的Allegro完整PTH分析。我们旨在评估其他甲状旁腺激素测定是否适合这些评估。我们使用三个血清池和七个人工加标的甲状旁腺激素样品,比较了五种商业免疫测定法测定的甲状旁腺激素浓度;使用总完整甲状旁腺激素测定作为参考测定。尽管甲状旁腺激素测定的结果显示出高度相关性,但其浓度与Yamasa的测定结果有所不同。并且第三/第二代测定比率约为60%。此外,Immulite分析高估了1-84 PTH的水平。我们在日本使用的甲状旁腺激素测定法中显示出重要的方法间差异。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号